Mycoplasmal arthritis infections can cause lameness, swollen joints and poor growth rates. These symptoms all negatively impact herd performance and therefore profitability. Mycoplasma hyorhinis bacteria causes this disease, but one of the ways it can be controlled is by administration of Vetmulin. The pharmacokinetics (PK) of Vetmulin in the plasma and the synovial fluid were investigated to predict the level of inhibition of mycoplasma.
The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.
To view all products and services, select Global from the dropdown menu or click .
Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.
Update your browser to view this website correctly. Update my browser now